361
Participants
Start Date
December 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Quetiapine Fumarate (SEROQUEL) Extended Release
Quetiapine fumarate extended release(XR) will be administered orally, once daily in the evening. The initial dose will be 50 mg. This dose will be adjusted on Day 2 to 100 mg, on Day 3 to 200 mg, and on Day 4 to 300 mg and after.
Placebo
Placebo matching quetiapine extended release(XR) 50 mg, 200 mg, and 300 mg tablets will be orally administered once daily, in the evening. The initial dose will be 50 mg. This dose will be adjusted on Day 2 to 100 mg, on Day 3 to 200 mg, and on Day 4 to 300 mg and after.
Research Site, Baoding
Research Site, Beijing
Research Site, Changsha
Research Site, Guangzhou
Research Site, Hangzhou
Research Site, Kunming
Research Site, Nanjing
Research Site, Shanghai
Research Site, Shanxi
Research Site, Tianjin
Research Site, Wuhan
Research Site, Xi'an
Lead Sponsor
AstraZeneca
INDUSTRY